Low miR-224–5p in exosomes confers colorectal cancer 5-FU resistance by upregulating S100A4
Drug Resistance Updates · 2025-03 · 79 · 101211
DOI: 10.1016/j.drup.2025.101211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2025-03. Verfasst von Yan-Yan Yan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respira…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, MicroRNAs, Fluorouracil, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Shanxi Province Natural Science Foundation, Health Commission of Shanxi Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
This study aimed to identify molecular markers that mediate 5-fluorouracil (5-FU) resistance in colorectal cancer (CRC). Exosomes from 5-FU resistant CRC cells (HCT-15/FU) significantly enhanced the resistance to 5-FU and the malignant properties of HCT-15 cells. Double screening of miRNAs in CRC cell-exosomes and serum-exosomes from clinical CRC patients revealed that miR-224-5p was expressed at significantly lower levels in the 5-FU resistant type than in the 5-FU sensitive type. Moreover, the overall survival rates of 5-FU-resistant CRC patients were much lower than those of 5-FU-sensitive CRC patients. Furthermore, cellular miRNA sequencing (miR-Seq) and proteomic studies revealed that several miRNAs such as miR-224-5p, were significantly downregulated and that calcium-related proteins, including S100 calcium-binding protein A4 (S100A4), were upregulated in HCT-15/FU cells. An analysis of data from public databases revealed that patients with CRC with lower S100A4 expression had a better prognosis. In addition, miR-224-5p was shown to directly target S100A4. Functionally, in vitro and in vivo experiments verified that the downregulation of miR-224-5p promoted malignant properties and resistance to 5-FU in HCT-15 cells, whereas the upregulation of miR-224-5p in HCT-15/FU cells attenuated these effects. Notably, 5-FU combined with verapamil reversed 5-FU resistance in CRC by regulating the miR-224-5p/S100A4 pathway. Triptolide inhibited the malignant properties of HCT-15/FU cells by affecting the miR-224-5p/S100A4 axis. Overall, miR-224-5p is involved in CRC 5-FU resistance by regulating S100A4, and might serve as a molecular marker for the early prediction and intervention of 5-FU resistance in CRC patients in the clinic. Triptolide or 5-FU combined with a calcium antagonist could be used as a trial therapy for 5-FU resistant CRC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliat…
- Institute of Immunology, School of Medicine, Shanxi Datong University, Datong 037009, PR China.
- Department of Gastroenterology, Cancer Center of Datong, The Second People's Hospital of Datong, Datong 037005, PR China.
- The Pathology Department of Shanxi Provincial People's Hospital, Taiyuan 030012, PR China.
Förderung
- Shanxi Province Natural Science Foundation
- Health Commission of Shanxi Province
- National Natural Science Foundation of China
- Shanxi Provincial Education Department
- National Key Research and Development Program of China
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Yan, Y. Y., Deng, Z. F., Wu, X. T., Lu, Y., Zhu, Z. Y., Wen, Q., Zhang, W., Zhang, H. Y., Chen, X. Z., Wu, Y. S., He, X. B., Ma, Z. A., Li, J. S., Bi, H., & Zhang, J. Y. (2025). Low miR-224–5p in exosomes confers colorectal cancer 5-FU resistance by upregulating S100A4. Drug Resistance Updates, 79, 101211. https://doi.org/10.1016/j.drup.2025.101211
Vancouver
Yan YY, Deng ZF, Wu XT, Lu Y, Zhu ZY, Wen Q, et al. Low miR-224–5p in exosomes confers colorectal cancer 5-FU resistance by upregulating S100A4. Drug Resistance Updates. 2025;79:101211. doi:10.1016/j.drup.2025.101211
BibTeX
@article{Yan2025,
author = {Yan, Yan-Yan and Deng, Zhuo-Fen and Wu, Xing-Tao and Lu, Yu and Zhu, Zhuang-Yan and Wen, Qing and Zhang, Wei and Zhang, Hai-Yan and Chen, Xin-Zhu and Wu, Yu-Song and He, Xue-Bing and Ma, Zi-Ang and Li, Jin-Shuo and Bi, Hong and Zhang, Jian-Ye},
title = {Low miR-224–5p in exosomes confers colorectal cancer 5-FU resistance by upregulating S100A4},
journal = {Drug Resistance Updates},
year = {2025},
volume = {79},
pages = {101211},
doi = {10.1016/j.drup.2025.101211}
}
EUVIMED